<DOC>
	<DOCNO>NCT00750529</DOCNO>
	<brief_summary>The aim study analysis two inhibitor Ach-E : galantamine donépézil 65 year ' old patient suffer Alzheimer disease ( MMSE 20 26 ) without Alzheimer 's medication .</brief_summary>
	<brief_title>Alzheimer Sleep</brief_title>
	<detailed_description>Feasibility study , open , randomize , control , cross-over study 65 year old patient .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>65 year old Patients suffer Alzheimer disease Patient live someone home Written consent give Galantamine Donepezil hypersensibility Patient live alone medicalized structure Concomitant medication Chronical disease</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>sleep</keyword>
	<keyword>Alzheimer</keyword>
	<keyword>old patient</keyword>
</DOC>